Apalutamide for the treatment of metastatic hormone-sensitive prostate cancer: a rapid health technology assessment

doi:10.3969/j.issn.1672-3384.2024.01.010

ZHU Yu-rong, YANG Tao, WANG Yu-bo, ZHANG Rui, ZHENG Hai-ying, HU Ya-guang

Clinical Medication Journal ›› 2024, Vol. 22 ›› Issue (1) : 46-50.

PDF(403 KB)

Clinical Medication Journal ›› 2024, Vol. 22 ›› Issue (1) : 46-50. DOI: 10.3969/j.issn.1672-3384.2024.01.010

Original Article

Apalutamide for the treatment of metastatic hormone-sensitive prostate cancer: a rapid health technology assessment

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2024, 22(1): 46-50 https://doi.org/10.3969/j.issn.1672-3384.2024.01.010

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(403 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2023-06-24	2024-01-31
Issue Date
2024-01-31

Please choose a citation manager

Content to export